Healthy Skepticism Library item: 5781
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Foote M.
Guidelines and policies for medical writers in the biotech industry: an update on the controversy.
Biotechnol Annu Rev 2004; 10:259-64:
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7CTS-4DN8YX3-7&_coverDate=12%2F31%2F2004&_alid=431466823&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=18058&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=867f3a71a0241a0bf5b894eb3c7bdec4
Abstract:
Papers reporting the results of clinical trials written by medical writers employed by the biotech and pharmaceutical industries have been criticized for possible bias in presentation and failure to adhere to authorship guidelines. Several groups have attempted to address the concerns of journal editors, academics, regulators, and the general public by issuing guidelines and policies for the preparation of such material.
Keywords:
Biotechnology/standards*
Clinical Trials/standards*
Documentation/standards*
Drug Industry/standards*
Guidelines*
Internationality
Organizational Policy*
Periodicals/standards*
